Investing.com - Ideaya Biosciences Inc reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Ideaya Biosciences Inc announced earnings per share of $0.04 on revenue of $29.7M. Analysts polled by Investing.com anticipated EPS of $-0.61 on revenue of $7.97M.
Ideaya Biosciences Inc shares are down 35% from the beginning of the year , still down 26.51% from its 52 week high of $24.71 set on Monday, November 22, 2021.
Ideaya Biosciences Inc shares gained 3.30% in intra-day trade the report.
Ideaya Biosciences Inc follows other major Healthcare sector earnings this month
Ideaya Biosciences Inc's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar